Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The characteristics of patients with chronic hepatitis B in Turkey.
Kemal Celen M, Tekin Koruk S, Aygen B, Dal T, Karabay O, Tosun S, Koksal I, Turgut H, Onlen Y, Balik I, Yildirim N, Sinan Dal M, Ayaz C, Tabak F. Kemal Celen M, et al. Among authors: aygen b. Med Glas (Zenica). 2014 Feb;11(1):94-8. Med Glas (Zenica). 2014. PMID: 24496347
Treatment of tuberculous meningitis in Turkey.
Doğanay M, Calangu S, Turgut H, Bakir M, Aygen B. Doğanay M, et al. Among authors: aygen b. Scand J Infect Dis. 1995;27(2):135-8. doi: 10.3109/00365549509018993. Scand J Infect Dis. 1995. PMID: 7660076 Clinical Trial.
Predictors of outcome in patients with tuberculous meningitis.
Hosoglu S, Geyik MF, Balik I, Aygen B, Erol S, Aygencel TG, Mert A, Saltoglu N, Dokmetas I, Felek S, Sunbul M, Irmak H, Aydin K, Kokoglu OF, Ucmak H, Altindis M, Loeb M. Hosoglu S, et al. Among authors: aygen b. Int J Tuberc Lung Dis. 2002 Jan;6(1):64-70. Int J Tuberc Lung Dis. 2002. PMID: 11931403
Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C.
Sargin Altunok E, Sayan M, Akhan S, Aygen B, Yildiz O, Tekin Koruk S, Mistik R, Demirturk N, Ural O, Kose Ş, Aynioglu A, Korkmaz F, Ersoz G, Tuna N, Ayaz C, Karakecili F, Keten D, Inan D, Yazici S, Koculu S, Yildirmak T. Sargin Altunok E, et al. Among authors: aygen b. Int J Infect Dis. 2016 Sep;50:1-5. doi: 10.1016/j.ijid.2016.07.003. Epub 2016 Jul 9. Int J Infect Dis. 2016. PMID: 27401586 Free article.
Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences.
Örmeci N, Sezgin O, Karaali R, Aygen B, Turan D, Yaras S, Erdem İ, Yildiz O, Karakaya F, Ateş K, Asiller ÖÖ. Örmeci N, et al. Among authors: aygen b. Eur J Gastroenterol Hepatol. 2019 Apr;31(4):534-539. doi: 10.1097/MEG.0000000000001334. Eur J Gastroenterol Hepatol. 2019. PMID: 30672829
67 results